BLNK and neoplasm: Additional evidence for a potential role of the BCR pathway in the pathogenesis of MCL was provided by phospho-proteomic analysis of MCL cell lines and primary tumor samples demonstrating constitutive activation of multiple BCR signaling molecules, including CD79B, LYN, SYK, BLNK, BTK, and PLCγ2 [130].